Salvador Mañé

Naxitamab combined with granulocyte‐macrophage colony‐stimulating factor as consolidation for high‐risk neuroblastoma patients in complete remission

Alicia Castañeda, Maite Gorostegui, Vicente Santa‐María et al. · Pediatric Blood & Cancer · 2021 · 30 citations

Medicine, Oncology, Pharmacotherapy +10

The Role of Autologous Stem-Cell Transplantation in High-Risk Neuroblastoma Consolidated by anti-GD2 Immunotherapy. Results of Two Consecutive Studies

Jaume Mora, Alicia Castañeda, Miguel Flores et al. · Frontiers in Pharmacology · 2020 · 23 citations · Full text

Medicine, Immunology, Oncology +17

Naxitamab Combined with Granulocyte-Macrophage Colony-Stimulating Factor as Consolidation for High-Risk Neuroblastoma Patients in First Complete Remission under Compassionate Use—Updated Outcome Report

Jaume Mora, Alicia Castañeda, Maite Gorostegui et al. · Cancers · 2023 · 21 citations · Full text

Medicine, Oncology, Pharmacotherapy +10

Results of induction chemotherapy in children older than 18 months with stage-4 neuroblastoma treated with an adaptive-to-response modified N7 protocol (mN7)

Jaume Mora, Ofelia Cruz, Cinzia Lavarino et al. · Clinical & Translational Oncology · 2015 · 15 citations

Medicine, Oncology, Pediatrics +3

Clinical and Pathological Evidence of Anti-GD2 Immunotherapy Induced Differentiation in Relapsed/Refractory High-Risk Neuroblastoma

Jaume Mora, Alicia Castañeda, María Laura Colombo et al. · Cancers · 2021 · 14 citations · Full text

Medicine, Oncology, Pharmacology +17